vomiting on glp 1 Cumulative incidence of nausea/vomiting caused by glucagon‐like GLP-1 shot reduces nausea symptoms

This decision is purely based on economics, not clinical evidence, and it is not in the best interest of patients, said Dr

However, it has been difficult to determine how long people remain on GLP-1 medications for obesity for several reasons: Drug shortages meant that some patients with prescriptions could not fill them

40 g/kg, i.p.) increases catalase and superoxide dismutase (SOD) activities and malonic dialdehyde (MDA) concentration in the liver homogenate of rats subjected to acute stress, but the opposite effects are observed at 120, and 360 g/kg[2]

So long as they had been properly stored and there were no signs of deterioration then they were safe to use